USP22 knockout dramatically suppressed in vivo angiogenesis, growth, and metastasis of NSCLC xenografts independent of their p53 status, and significantly prolonged survival of metastatic cancer-bearing mice. Here, USP22 is linked to metastatic malignant neoplasm.